发明名称 QUINOLINE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY
摘要 The invention relates to compounds of formula (I) wherein: either any one of G1, G2, G3, G4 and G5 is nitrogen and the other four are -CH-, or G1, G2, G3, G4 and G5 are all -CH-; Z is -O-, -NH-, -S-, -CH2- or a direct bond; Z is linked to any one of G1, G2, G3 and G4; n is an integer from 0 to 5; m is an integer from 0 to 3; R<a> represents hydrogen or fluoro; R<b>, R<1> and R<2> are defined herein and salt thereof, process for the preparation so such compounds, pharmaceutical compositions containing a compound of formula I or a pharmaceutically acceptable salt thereof as active ingredient and the use of a compound of formula I in the manufacture of a medicament for the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blodded animals. The compounds of formula I and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of diseases states including cancer and rheumatoid arthritis.
申请公布号 WO0212226(A1) 申请公布日期 2002.02.14
申请号 WO2001GB03553 申请日期 2001.08.08
申请人 ASTRAZENECA AB;ASTRAZENECA UK LIMITED;HENNEQUIN, LAURENT, FRANCOIS, ANDRE 发明人 HENNEQUIN, LAURENT, FRANCOIS, ANDRE
分类号 A61K31/47;A61K31/4709;A61K31/496;A61K31/541;A61P3/10;A61P9/00;A61P9/10;A61P13/12;A61P15/00;A61P17/06;A61P27/02;A61P29/00;A61P35/00;A61P37/02;A61P43/00;C07D401/12;C07D401/14;C07D405/14;C07D417/14;(IPC1-7):C07D401/14 主分类号 A61K31/47
代理机构 代理人
主权项
地址